BioElectronics and YesDTC Holdings Receive Japanese Regulatory Review Date

FREDERICK, Md., July 27 /PRNewswire-FirstCall/ —
BioElectronics Corp. (Pink Sheets: BIEL), manufacturers of
innovative pain relieving medical devices, today announced its
distribution partner for Japan,
YesDTC Holdings, Inc. (OTC Bulletin Board: YESD) has received
notification from its legal staff of the pending review by Japanese
government medical device regulators for the ActiPatch™ and
Allay™ Menstrual Relief products.  This review will take
place on Wednesday, July 28th.

The initial analysis by YesDTC’s attorneys has been very
favorable toward the Company’s ability to begin marketing in Japan as several similar devices are
already on the market.  This regulatory review is designed to
verify that Japanese regulatory agencies will place ActiPatch and
Allay in the same category as these currently marketed devices or
if additional information and or testing will be required.
 

BioElectronics and YesDTC recently announced several important
product line enhancements specifically tailored to suit the needs
of the highly discerning and quality conscious Japanese
marketplace.  Additionally, upon release, BioElectronics will
make the recently announced back pain belt available to the
Japanese marketplace.

Andrew Whelan, CEO of
BioElectronics, commented, “We view the Japanese market as being
significant to our future success.  There is a history of
Japanese regulators closely mirroring the medical device
classifications that had earlier occurred within the European
Union, where we are a Class IIa device.  This pending review,
which will take place this week, should offer us a great deal of
information about the timing in what we bel

‘/>”/>

SOURCE